SHAILI PATEL: Open Payments
NPI 1538171459 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 17 payments from 11 companies in 2025. Trend: 2023 $531 · 2024 $318 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $108 |
| Alkermes, Inc. | 2 | $51 |
| Corium, LLC | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Vertical Pharmaceuticals, LLC | 2 | $40 |
| Lundbeck LLC | 2 | $39 |
| ABBVIE INC. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: REXULTI, LYBALVI, Azstarys, CAPLYTA, Jornay PM, Relexxii, VRAYLAR, Auvelity.
Industry payments across AZ — which companies pay providers there.
